Homology Medicines, Inc. (FIXX)

NASDAQ: FIXX · IEX Real-Time Price · USD
2.76
-0.09 (-3.16%)
At close: Aug 12, 2022 4:00 PM
2.89
+0.13 (4.71%)
After-hours: Aug 12, 2022 5:22 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 202120202019201820172016
Revenue
33.972.71.675.3200
Revenue Growth (YoY)
1157.25%62.19%-68.70%---
Gross Profit
33.972.71.675.3200
Selling, General & Admin
36.8432.5722.2117.38.284.31
Research & Development
93.09100.3989.447.9521.385.69
Operating Expenses
129.92132.97111.6165.2529.6610
Operating Income
-95.95-130.26-109.94-59.93-29.66-10
Other Expense / Income
-0.19-1.57-6.03-4.350.33-1.95
Pretax Income
-95.76-128.69-103.92-55.58-29.99-8.05
Net Income
-95.76-128.69-103.92-55.58-29.99-8.05
Net Income Common
-95.76-128.69-103.92-55.58-29.99-8.05
Shares Outstanding (Basic)
5546422922
Shares Outstanding (Diluted)
5546422922
Shares Change
20.41%9.01%47.51%1051.55%30.46%-
EPS (Basic)
-1.73-2.80-2.47-1.95-12.10-4.23
EPS (Diluted)
-1.73-2.80-2.47-1.95-12.10-4.23
Free Cash Flow Per Share
-2.03-2.14-2.69-2.361.82-5.51
Gross Margin
100.00%100.00%100.00%100.00%--
Operating Margin
-282.40%-4821.00%-6599.20%-1126.00%--
Profit Margin
-281.90%-4762.90%-6237.50%-1044.30%--
Free Cash Flow Margin
-330.10%-3629.30%-6794.20%-1268.30%--
EBITDA
-86.22-119.79-97.6-54.29-29.31-7.81
EBITDA Margin
-253.80%-4433.40%-5858.20%-1020.10%--
Depreciation & Amortization
9.548.96.321.290.680.24
EBIT
-95.76-128.69-103.92-55.58-29.99-8.05
EBIT Margin
-281.90%-4762.90%-6237.50%-1044.30%--
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).